Majd Alkabbani

Hamad Medical Corporation

Papers

1

Total Citations

2

H-Index

1

About

Dr. Majd Alkabbani is a pathologist whose research centers on the diagnostic characterization of rare and emerging renal neoplasms. Her most notable contribution is a detailed case report on tubulocystic renal cell carcinoma (RCC), a rare tumor only recognized as a distinct entity by the World Health Organization in 2016. In this work, she documents the incidental diagnosis of the tumor in a 35-year-old male, emphasizing its typically indolent clinical behavior and low metastatic potential. By providing a comprehensive histopathological and clinical profile of this uncommon malignancy, Dr. Alkabbani’s study aids in refining diagnostic criteria and raising awareness among clinicians and pathologists. Her work has garnered early citations, reflecting its relevance to the growing body of literature on rare kidney cancers. Through her focused investigation of tubulocystic RCC, Dr. Alkabbani contributes valuable insights into the classification and management of challenging urological tumors, supporting more accurate diagnosis and improved patient outcomes in this specialized field.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Tubulocystic renal cell carcinoma: A case report of rare tumor
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Hamad Medical Corporation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago